47.73.Z - Retail sale of pharmaceutical products
21.10.Z - Manufacture of basic pharmaceutical products
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
47.74.Z - Retail sale of medical and orthopedic products
47.91.Z - Intermediary retail sale, non-specialized
49.41.Z - Road freight transport
86.90.E - Healthcare
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale | 0,6 | 1,1 | 1,3 | 23,1 |
Gross profit (loss) | 0,6 | 1 | 1,3 | 19,4 |
EBITDA | 0,6 | 1 | 1,3 | 27,5 |
Short time liabilities | 4,4 | 5,3 | 6,1 | 15,8 |
Other operating costs | 0 | 0 | 0,2 | 431,6 |
Equity capital | 2,1 | 2,4 | 1,2 | -51 |
Operating profit (EBIT) | 0,6 | 1 | 1,3 | 19,5 |
Assets | 6,5 | 7,7 | 7,3 | -5,3 |
Net profit (loss) | 0,6 | 1 | 1,3 | 19,4 |
Cash | 2,4 | 2,1 | 1 | -52,6 |
Liabilities and provisions for liabilities | 4,4 | 5,3 | 6,1 | 15,8 |
Net income from sale | 27,8 | 33,4 | 37,6 | 12,4 |
Working assets | 6,4 | 7,6 | 7,2 | -4,3 |
Other income costs | 0,1 | 0 | 0,1 | 885,3 |
Depreciation | 0 | 0 | 0,1 | -∞ |
% | % | % | p.p. | |
Profitability of capital | 30,1 | 43,2 | 105,3 | 62,1 |
Equity capital to total assets | 32,8 | 31,6 | 16,3 | -15,3 |
Gross profit margin | 2,3 | 3,1 | 3,3 | 0,2 |
EBITDA Margin | 2,3 | 3,1 | 3,6 | 0,5 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 57 | 58 | 59 | 1 |
Current financial liquidity indicator | 1.45881986618042 | 1.4367223978042603 | 1.1878663301467896 | -0,2 |
Net dept to EBITDA | -3.774461507797241 | -2.0274598598480225 | -0.7529333233833313 | 1,2 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane